Accordingly, a recent analysis of Treg subsets in Her2/Neu-expressing mammary tumor-bearing mice revealed the existence of a Cy-sensitive CD4+Foxp3+CD25+ subset with tumor-seeking migratory phenotype, characteristic of amTregs, and capable of high avidity T-cell suppression (109). The gene discussed is ERBB2; the disease is breast cancer.